Navigation Links
Web Page to Warn Against Online Purchase of Isotretinoin

On Wednesday, the FDA launched a special Web page. This web page is aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche// under the brand name Accutane, on the Internet.

The drug claims to cure severe acne that is not controlled by other treatment forms. FDA warns that if used improperly, the drug causes birth defects and severe mental health problems.

The FDA warning page appears in online search results for Accutane (isotretinoin) or its other generic versions(Amnesteem, Claravis, or Sotret) FDA advises that this drug be taken only under the direction of a physician or a pharmacist.

Isotretinoin manufacturers have already issued safeguards to reduce the risks of the drug, like the iPLEDGE risk management program. They warn women using isotretinoin to stop using the drug in case of pregnancy and pregnant women not to use isotretinoin.

Research studies have revealed that isotretinoin causes severe side effects in expectant mothers, such as birth defects and fetal death, and also might cause depression and suicide.

FDA data released in 2004 showed that these measures had little effect on the number of pregnant women taking the drug.

The FDA began to register physicians, prescription drug wholesalers, pharmacists and women into iPledge, since Dec. 30, 2005, which asks women to submit two negative pregnancy tests in order to receive a prescription for isotretinoin.

Women have to undergo a pregnancy test every month and must accept to use two different forms of birth control at the time of treatment with isotretinoin and for one month after treatment has ended, according to FDA.

Women also have to sign a text to acknowledge that isotretinoin can amplify risk for birth defects, depression and suicidal thoughts. About 165,000 people have registered with iPledge, which FDA administers jointly with companies that sell the drug.

The Web page was launched as FDA officials' felt that some are purchasing the drug on line to avoid involvement in iPledge.

The Web page has links to other info about the drug, including a link to iPledge. The Web page gets connected when people search for Accutane, or any of its three generic versions -- Amnesteem from Mylan Laboratories, Claravis from Barr Pharmaceuticals and Sotret from Ranbaxy Laboratories.
PRI
'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. New Weapon Against Germs
4. Estrogen Found To Protect the Colon Against Cancer
5. Diet Found To Offer Protection Against Leukemia
6. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
7. WHO Issues Caution Against Bird Flu Epidemic
8. New Supplement Found To Be Effective Against Sunburn
9. Intense Fight Against Polio In India Gets Results
10. Prime Minister Manmohan Against Incentive-Based Population Control
11. Scientists Warn Against Food Borne Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... 28, 2017 , ... Quorum Health announced that Robert A. Vento has been ... John Maher was promoted to COO of QHR. , A national search ... president and CEO in December 2016. , “I’m pleased to announce ...
(Date:6/28/2017)... ... ... Drs. Steven Crandall, Karen Johnson and Kathy Lopez are now accepting new ... PA, without a referral. The doctors address jaw pain and other symptoms ... facial muscles that support it. , Jaw pain can be debilitating, and when ...
(Date:6/28/2017)... ... ... remote control has seen the never-ending twists on the house flipping show genre. The shows ... time. But what about the buyers of the flipper's flip. , Here is ... An email recently sent to Gary Case said, “Just closed on a home on ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton ... for mid-market executives as a kick-off to the fifth annual CEO Connection Mid-Market ... on the University of Pennsylvania campus, followed by the two-day convention, which will ...
(Date:6/28/2017)... Vancouver, British Columbia (PRWEB) , ... June 28, ... ... (OTCQB: CNZCF) (FSE: ZEON) is pleased to announce that a two year study ... using the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
(Date:6/8/2017)... LOS ANGELES , June 8, 2017   Responding ... prescription drug oversight and the death of singer Chris ... Commission on Human Rights International offers a free online ...  to better educate consumers and families about psychotropic drug risks. ... Heath Ledger , who died from an accidental overdose, has ...
Breaking Medicine Technology: